Alison L. Hannah - 01 Jun 2025 Form 4/A - Amendment Insider Report for NEOGENOMICS INC (NEO)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
03 Jun 2025, 18:19:50 UTC
Original report date
03 Jun 2025
Prior SEC filing
28 May 2025
Next SEC filing
19 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ali Olivo, Attorney-in-Fact

Key filing fact

Alison L. Hannah filed Form 4/A - Amendment for NEOGENOMICS INC (NEO) on 03 Jun 2025.

Key facts

  • This page summarizes Alison L. Hannah's Form 4/A - Amendment filing for NEOGENOMICS INC (NEO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Jun 2025, 18:19.

Change

  • Previous filing in this sequence was filed on 28 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001645600 Primary reporting owner

HANNAH ALISON L.

Relationship
Director
Address
9490 NEOGENOMICS WAY, FORT MYERS
Signature
/s/ Ali Olivo, Attorney-in-Fact
Signature date
03 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+12,254
Change %
+10%
Price
$0.000000
Shares after
131,023
Date
01 Jun 2025
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Due to clerical error, this amendment to Form 4 is being filed to correct the transaction code in the reported transaction.

Footnote F2

As reported in the original Form 4, reflects the release of restricted stock units that were previously reported on a Form 4.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .